GlassScriptPhysician profile
Sherry Lynn Denton
NPI 1851726707
$23,285.11
in general payments reported to CMS, 2019-2025
40 companies · $6,430 in 2025
The $6,430 reported for 2025 was more than what 98% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,404 · 2022: $468 · 2023: $3,783 · 2024: $7,201 · 2025: $6,430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,274.90 |
| Education | $138.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $7,450.46 | 2021-2025 | Provenge |
| Janssen Biotech, INC. | $3,003.22 | 2021-2025 | Erleada, Carvykti, Rybrevant |
| Sumitomo Pharma America, INC. | $1,858.96 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $1,653.62 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $1,374.75 | 2021-2024 | Prolaris |
| Abbvie INC. | $909.17 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $838.54 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $680.70 | 2022-2025 | Pylarify |
| Myovant Sciences INC. | $584.61 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $540.69 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $514.02 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Janssen Scientific Affairs, LLC | $500.00 | 2021 | |
| Blue Earth Diagnostics | $463.69 | 2021-2025 | Posluma |
| Astellas Pharma US INC | $435.18 | 2021-2025 | Xtandi |
| Ferring Pharmaceuticals INC. | $351.76 | 2024-2025 | Adstiladrin |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $312.80 | 2021-2025 | Spaceoar Vue System - 10ml, Ams 700, Advantage System |
| Tolmar, INC. | $253.81 | 2023-2024 | |
| Calyxo, INC. | $199.31 | 2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $192.02 | 2021-2025 | Jelmyto |
| Immunitybio, INC. | $143.66 | 2025 | |
| 180 Medical, INC. | $129.80 | 2023-2025 | Gentlecath Glide |
| Astrazeneca Pharmaceuticals LP | $122.43 | 2021-2025 | Lynparza |
| Coloplast Corp | $116.16 | 2023-2025 | Luja Coude, Speedicath |
| Profound Medical Corp. | $103.53 | 2025 | Tulsa-Pro |
| Amgen INC. | $86.18 | 2021 | |
| Teleflex LLC | $74.57 | 2023-2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $47.34 | 2021-2024 | Aveed, Xiaflex, Edex |
| Alnylam Pharmaceuticals INC. | $47.31 | 2023-2025 | Oxlumo, Givlaari |
| Laborie Medical Technologies Corp. | $42.79 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Vertex Pharmaceuticals Incorporated | $40.16 | 2024-2025 | |
| Telix Pharmaceuticals | $34.26 | 2024 | Illuccix |
| Sun Pharmaceutical Industries INC. | $31.79 | 2024 | |
| Bioprotect Medical, INC. | $22.65 | 2025 | Bioprotect Balloon Implant System |
| Procept Biorobotics Corporation | $21.17 | 2025 | |
| Tempus Ai, INC | $20.94 | 2024 | |
| Endo USA, INC. | $19.84 | 2025 | Aveed, Xiaflex |
| Inspire Medical Systems, INC. | $18.52 | 2025 | Inspire |
| Becton, Dickinson and Company | $16.65 | 2023 | Bd Max System, Bd Max Instrument |
| Urovant Sciences INC | $14.20 | 2021 | |
| Accord Healthcare, INC. | $13.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherry Denton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.